White paper on the future chemical policy in the European Union - implications for animal welfare.

In February 2001, the European Commission adopted a White Paper on a Future Chemicals Policy. Its main goals are better to protect humans and the environment from unknown risks through chemicals. The "promotion of non-animal testing" is one of the key elements of the proposed strategy. For low production volume chemicals, only data from in vitro-tests are to be requested. The data requirements for higher production volume chemicals shall be designed flexibly so that only data relevant for the respective chemical are collected. From the point of view of animal welfare concrete risk management strategies should be defined before test batteries are put together. The test catalogues currently listed in the Classification Directive 67/548/EEC are to be replaced by tiered testing strategies, and concrete waiving strategies are to be designed so that the requested tailor-made testing can actually be realized. Another essential prerequisite for the promotion of non-animal testing is that the funding of alternative method research is formulated as a key action with a concrete budget in the Sixth Research Framework Program of the European Union.

[Reasons for not using primates in research]. / Uber die Notwendigkeit, auf Versuche an Primaten zu verzichten.

In terms of physiological development, non-human primates are our next of kin in the animal kingdom. Scientists who oppose the use of primates for experimental purposes argue that due to the high degree of similarity between primates and humans, experiments that may not be performed on humans due to ethical reasons also should not be performed on primates. Taking neurophysiological experiments with primates as an example, it is discussed which consequences it would have for medical progress if the use of primates in research were abandoned altogether. Taking into account the alternatives available and the results gained with the animal tests, it is concluded that medical progress would be unimpeded, even though in some instances the exact same questions that currently are evaluated with the animal tests might no longer be pursued with the alternatives.

Developments in the Collection of Statistical Information on the Number of Animals used in Experiments and other Scientific Purposes in the European Union.

In 1999, the European Commission presented its second report on the numbers of laboratory animals used in the European Union (EU). The plausibility of the data and the usefulness of the format of the registration tables remain questionable, for reasons previously discussed in connection with the Commission` s first statistical report. In addition, it is impossible to derive sound information on trends in animal use in the EU and its Member States from the second statistical report. The European Commission and the Member States have agreed on new tables to be used for future statistics on the use of experimental animals in the EU. These new tables have been significantly extended and improved. Several categories of little relevance have been revised, and ambiguous expressions have been clarified. However, several problems either persist or have been newly created. Moreover, some important data (i.e. categories for pain and distress, as well as for several specific purposes of use; the origin of some animal species; types of institutions; and the use of genetically engineered animals) are still not required. Nevertheless, these are highly relevant to animal welfare and must be regarded as indispensable for a well-aimed application of the statistics to set priorities concerning the Three Rs.

Toxicity testing of polymer materials for dialysis equipment: reconsidering in vivo testing.

In fulfilment of the aims of the European Union Biocidal Directive (Directive 98/8/EC), Technical Guidance Documents are currently being compiled. Part I of these Technical Guidance Documents covers data requirements for active substances and biocidal products. The Three Rs principle has been applied in certain parts of the toxicity and ecotoxicity testing scheme for pesticides, such as testing for acute oral toxicity, skin and eye irritation, skin sensitisation, and dermal absorption. Further recommendations on how to proceed with regard to the continuing replacement, reduction and refinement of animal experiments in this field of regulatory testing are included for consideration. In this context, besides stressing the necessity to validate and accept further alternatives, emphasis is placed on providing the possibility of waiving unnecessary tests and on the continuous evaluation of whether certain tests are needed at all.

Glutamine and glutamate in ascitic fluid of dogs.

The amino acid pattern in the ascites of 79 dogs was examined. The concentration of glutamine in neoplastic ascites is significantly lower than in cardial effusions. In contrast, glutamate is significantly higher in neoplastic ascites than in cardial ascites. Using an arbitrary discrimination value of 0.28 for the glutamate/glutamine ratio, purulent or cardial ascites are easily differentiated, with a sensitivity of 100% and a specificity of 94%. The differentiation is very distinct, with no overlap between the group of patients with liver cirrhosis on the one hand and the groups of patients with purulent peritonitis, heart failure, or malignant ascites on the other hand. There was no diagnostically unsable correlation between the concentrations of the other 20 amino acids and the underlying causes of ascites formation.

[Cellulose acetate electrophoresis, radial immunodiffusion and nephelometry--comparative methods for the determination of albumin]. / Cellulose-Acetatfolien-Elektrophorese, radiale Immunodiffusion und Nephelometrie--Methodenvergleich im Rahmen der Albuminbestimmung.

Different methods for the determination of albumin in dogs and cats are compared. Nephelometry was found to be the method of choice, due to its excellent precision, the immediate test results and the wide measuring range. The advantage of the radial immunodiffusion method is that expensive equipment need not be acquired, which makes the test profitable for small amounts of samples. At the expense of accuracy, electrophoresis enables the simultaneous evaluation of all protein fractions.

[Clinico-chemical study of body cavity effusions]. / Klinisch-chemische Untersuchung von Körperhöhlenergüssen.

The differential diagnosis of ascites is discussed. 107 dogs with ascites were examined. The mean age of the dogs was relatively high. Therefore many dogs were multimorbid. The classification of ascites into transudate and exudate was of limited value. The activity of the lactate dehydrogenase (LDH) in the ascitic fluid was a potent parameter in differentiating cardiac, neoplastic and infectious ascites. For the diagnosis of a neoplastic cause of the ascites, a LDH activity range from 200-1600 U/l was useful. The predictive value of the positive result was 87%, and the predictive value of the negative result was 88%.